Chong Kun Dang Holdings Corp. (001630.KS)
KRW 50100.0
(-0.6%)
KRW 50100.0
(-0.6%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 194.76 Billion KRW | 3.33% |
| 2022 | 188.49 Billion KRW | 7.14% |
| 2021 | 175.93 Billion KRW | 7.02% |
| 2020 | 164.39 Billion KRW | 40.32% |
| 2019 | 117.15 Billion KRW | 21.51% |
| 2018 | 96.41 Billion KRW | 7.54% |
| 2017 | 89.64 Billion KRW | -7.65% |
| 2016 | 97.07 Billion KRW | 70.66% |
| 2015 | 56.88 Billion KRW | 31.95% |
| 2014 | 43.1 Billion KRW | 33.87% |
| 2013 | 32.2 Billion KRW | -66.3% |
| 2012 | 95.56 Billion KRW | 24.45% |
| 2011 | 76.78 Billion KRW | -0.59% |
| 2010 | 77.24 Billion KRW | 18.09% |
| 2009 | 65.41 Billion KRW | 8.6% |
| 2008 | 60.23 Billion KRW | 14.19% |
| 2007 | 52.74 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 205.04 Billion KRW | 5.43% |
| 2024 Q1 | 194.47 Billion KRW | -0.15% |
| 2023 FY | 194.76 Billion KRW | 3.33% |
| 2023 Q2 | 186.62 Billion KRW | 5.23% |
| 2023 Q1 | 177.33 Billion KRW | -5.92% |
| 2023 Q4 | 194.76 Billion KRW | 0.57% |
| 2023 Q3 | 193.66 Billion KRW | 3.77% |
| 2022 Q1 | 171.67 Billion KRW | -2.42% |
| 2022 Q2 | 173.64 Billion KRW | 1.15% |
| 2022 Q4 | 188.49 Billion KRW | 0.28% |
| 2022 Q3 | 187.97 Billion KRW | 8.25% |
| 2022 FY | 188.49 Billion KRW | 7.14% |
| 2021 Q4 | 175.93 Billion KRW | 11.91% |
| 2021 Q3 | 157.21 Billion KRW | -9.26% |
| 2021 Q2 | 173.26 Billion KRW | 0.13% |
| 2021 Q1 | 173.04 Billion KRW | 5.26% |
| 2021 FY | 175.93 Billion KRW | 7.02% |
| 2020 Q1 | 127.69 Billion KRW | 9.0% |
| 2020 Q2 | 142.17 Billion KRW | 11.34% |
| 2020 FY | 164.39 Billion KRW | 40.32% |
| 2020 Q3 | 150.95 Billion KRW | 6.18% |
| 2020 Q4 | 164.39 Billion KRW | 8.9% |
| 2019 Q2 | 113.75 Billion KRW | 7.13% |
| 2019 FY | 117.15 Billion KRW | 21.51% |
| 2019 Q4 | 117.15 Billion KRW | 2.58% |
| 2019 Q1 | 106.18 Billion KRW | 10.14% |
| 2019 Q3 | 114.2 Billion KRW | 0.39% |
| 2018 FY | 96.41 Billion KRW | 7.54% |
| 2018 Q1 | 89.92 Billion KRW | 0.31% |
| 2018 Q2 | 94.52 Billion KRW | 5.12% |
| 2018 Q3 | 96.8 Billion KRW | 2.41% |
| 2018 Q4 | 96.41 Billion KRW | -0.41% |
| 2017 FY | 89.64 Billion KRW | -7.65% |
| 2017 Q4 | 89.64 Billion KRW | -4.14% |
| 2017 Q3 | 93.52 Billion KRW | 0.52% |
| 2017 Q2 | 93.03 Billion KRW | -5.46% |
| 2017 Q1 | 98.41 Billion KRW | 1.38% |
| 2016 FY | 97.07 Billion KRW | 70.66% |
| 2016 Q4 | 97.07 Billion KRW | 3.92% |
| 2016 Q2 | 58.02 Billion KRW | -1.93% |
| 2016 Q1 | 59.17 Billion KRW | 4.03% |
| 2016 Q3 | 93.41 Billion KRW | 60.98% |
| 2015 FY | 56.88 Billion KRW | 31.95% |
| 2015 Q4 | 56.88 Billion KRW | 14.61% |
| 2015 Q3 | 49.62 Billion KRW | 1.19% |
| 2015 Q2 | 49.04 Billion KRW | 12.01% |
| 2015 Q1 | 43.78 Billion KRW | 1.58% |
| 2014 Q4 | 43.1 Billion KRW | 7.33% |
| 2014 FY | 43.1 Billion KRW | 33.87% |
| 2014 Q3 | 40.16 Billion KRW | 7.01% |
| 2014 Q2 | 37.53 Billion KRW | 8.78% |
| 2014 Q1 | 34.5 Billion KRW | 7.15% |
| 2013 Q2 | 99.82 Billion KRW | -1.67% |
| 2013 Q3 | 106.61 Billion KRW | 6.8% |
| 2013 Q4 | 32.2 Billion KRW | -69.8% |
| 2013 FY | 32.2 Billion KRW | -66.3% |
| 2013 Q1 | 101.52 Billion KRW | 6.24% |
| 2012 FY | 95.56 Billion KRW | 24.45% |
| 2012 Q4 | 95.56 Billion KRW | 0.0% |
| 2012 Q1 | 57.51 Billion KRW | 0.0% |
| 2011 Q1 | 60.53 Billion KRW | 0.0% |
| 2011 Q3 | 59.68 Billion KRW | -5.46% |
| 2011 FY | 76.78 Billion KRW | -0.59% |
| 2011 Q2 | 63.13 Billion KRW | 4.3% |
| 2010 Q2 | 48.12 Billion KRW | 3.58% |
| 2010 Q1 | 46.45 Billion KRW | 0.0% |
| 2010 FY | 77.24 Billion KRW | 18.09% |
| 2010 Q3 | 47.98 Billion KRW | -0.28% |
| 2009 Q1 | 45.23 Billion KRW | 0.0% |
| 2009 FY | 65.41 Billion KRW | 8.6% |
| 2009 Q3 | 41.84 Billion KRW | -5.04% |
| 2009 Q2 | 44.06 Billion KRW | -2.59% |
| 2008 Q1 | 32.73 Billion KRW | 0.0% |
| 2008 Q2 | 29.81 Billion KRW | -8.93% |
| 2008 Q3 | 31.43 Billion KRW | 5.45% |
| 2008 FY | 60.23 Billion KRW | 14.19% |
| 2007 Q3 | 27.77 Billion KRW | 1.41% |
| 2007 FY | 52.74 Billion KRW | 0.0% |
| 2007 Q1 | 28.23 Billion KRW | 0.0% |
| 2007 Q2 | 27.39 Billion KRW | -2.96% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -341.122% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | -65.262% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -113.637% |
| HANDOK Inc. | 94.46 Billion KRW | -106.178% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -816.839% |
| Yuhan Corporation | 284.75 Billion KRW | 31.604% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | -67.448% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -1097.913% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 32.564% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -501.42% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -215.538% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -899.971% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -543.208% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -302.845% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -341.122% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -523.432% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -453.68% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -304.679% |
| JW Holdings Corporation | 147.58 Billion KRW | -31.964% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -130.155% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 25.501% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -83.582% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -261.189% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -621.405% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -499.066% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -77.433% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -341.122% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | -3.245% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 19.367% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -83.582% |
| Yuhan Corporation | 284.75 Billion KRW | 31.604% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | -55.464% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -214.205% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 25.045% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -83.582% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -144.671% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -296.331% |
| CKD Bio Corp. | 69.08 Billion KRW | -181.932% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -85.353% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -175.492% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -260.289% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -261.189% |
| Boryung Corporation | 189.8 Billion KRW | -2.613% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -242.704% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -215.538% |
| JW Lifescience Corporation | 23.39 Billion KRW | -732.378% |